CNS Pharmaceuticals, Inc.
CNSP
$4.59
-$0.30-6.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -59.02% | -27.00% | -18.68% | -7.03% | 101.93% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 28.48% | -42.29% | -25.57% | 204.96% | -49.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -40.22% | 4.12% | 207.75% | -31.07% | 0.00% |
| Total Current Assets | -49.67% | -28.87% | -19.42% | 3.03% | 58.48% |
|
|
|||||
| Total Current Assets | -49.67% | -28.87% | -19.42% | 3.03% | 58.48% |
| Net Property, Plant & Equipment | 24.29% | 470.97% | -18.42% | -22.45% | -18.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.90% | 6.03% | 29.51% | 1,535.27% | -38.46% |
| Total Assets | -46.04% | -27.35% | -18.19% | 5.52% | 58.02% |
|
|
|||||
| Total Accounts Payable | 15.32% | 95.63% | 52.91% | -50.90% | 16.84% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -29.28% | 966.88% | -74.71% | -42.19% | -35.39% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.74% | 109.33% | 41.67% | -50.24% | 10.10% |
|
|
|||||
| Total Current Liabilities | 11.74% | 109.33% | 41.67% | -50.24% | 10.10% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -29.28% | 966.88% | -74.71% | -42.19% | -35.39% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.74% | 109.33% | 41.67% | -50.24% | 10.10% |
|
|
|||||
| Common Stock & APIC | 0.46% | 0.55% | 0.00% | 4.54% | 10.04% |
| Retained Earnings | -4.92% | -6.31% | -3.53% | -2.68% | -5.09% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -98.44% | -54.36% | -24.49% | 19.64% | 77.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -98.44% | -54.36% | -24.49% | 19.64% | 77.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -98.44% | -54.36% | -24.49% | 19.64% | 77.61% |
|
|
|||||